Contrary to the conventional view that inhibitors are employed to reduce PD-1/PD-L1 pathway levels to enhance immunity, the present study demonstrates that elevated levels of PD-1/PD-L1 expression hold positive significance in the immune regulation of AF. This evidence concerns the gene PDCD1 and atrial fibrillation.